RELATIONSHIP BETWEEN PHARMACOKINETIC AND PHARMACODYNAMIC BEHAVIOR OF BUFURALOL AND ITS METABOLITE RO-3-7410 IN HYPERTENSIVE PATIENTS

被引：9

作者：

ECKERT, M

COCCO, G

STROZZI, C

HEIZMANN, P

SFRISI, C

机构：

[1] UNIV FERRARA,SCH MED,INST GEN MED CLIN & THERAPEUT,I-44100 FERRARA,ITALY

[2] F HOFFMANN LA ROCHE & CO LTD,DEPT BIOL & PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 24卷 / 04期

关键词：

D O I：

10.1007/BF00609890

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：479 / 484

页数：6

共 7 条

[1] INFLUENCE OF RENAL-FAILURE ON THE HEPATIC-CLEARANCE OF BUFURALOL IN MAN [J].

BALANT, L ;

FRANCIS, RJ ;

TOZER, TN ;

MARMY, A ;

TSCHOPP, JM ;

FABRE, J .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :421-438

[2]

BALANT L, 1978, PHARM ACTA HELV, V53, P307

[3] THE GENETIC-CONTROL OF BUFURALOL METABOLISM IN MAN [J].

DAYER, P ;

BALANT, L ;

COURVOISIER, F ;

KUPFER, A ;

KUBLI, A ;

GORGIA, A ;

FABRE, J .

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (01) :73-77

[4]

DENTRY JMR, 1973, CORONARY HEART DISEA, P21

[5] DETERMINATION OF BUFURALOL AND ITS MAJOR METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

HAEFELFINGER, P .

JOURNAL OF CHROMATOGRAPHY, 1980, 221 (02) :327-335

[6]

MAGOMETSCHNIGG D, 1979, INT J CLIN PHARM BI, V17, P334

[7]

ROSTAN A, 1978, PRAXIS, V67, P27

← 1 →